Imatinib Mesylate Tablets
A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.
| Catalog Number | API220127571-3 |
| Alternative Name(s) | Gleevec Glivec Imatinib mesilate |
| Research Area | Anti-Tumor APIs |
| Molecular Formula | C30H35N7O4S |
| CAS# | 220127-57-1 |
| SMILES | CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/imatinib-mesylate-tablets-item-11803.html |